Canada markets closed

NextCure, Inc. (NXTC)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.4000+0.0200 (+1.45%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
22,378
Operating Expenses
Research Development
46,653
47,931
54,199
50,192
46,554
Selling General and Administrative
17,011
19,706
21,710
20,573
17,049
Total Operating Expenses
63,664
67,637
75,909
70,765
63,603
Operating Income or Loss
-63,664
-67,637
-75,909
-70,765
-41,225
Total Other Income/Expenses Net
2,385
4,914
1,176
1,376
4,622
Income Before Tax
-61,279
-62,723
-74,733
-69,389
-36,603
Income from Continuing Operations
-61,279
-62,723
-74,733
-69,389
-36,603
Net Income
-61,279
-62,723
-74,733
-69,389
-36,603
Net Income available to common shareholders
-61,279
-62,723
-74,733
-69,389
-36,603
Basic EPS
-2.35
-2.25
-2.69
-2.51
-1.33
Diluted EPS
-2.35
-2.25
-2.69
-2.51
-1.33
Basic Average Shares
27,804
27,837
27,744
27,616
27,532
Diluted Average Shares
27,804
27,837
27,744
27,616
27,532